Cargando…
Inhibitory Effect of Punicalagin on Inflammatory and Angiogenic Activation of Human Umbilical Vein Endothelial Cells
Punicalagin, a major ellagitannin isolated from pomegranate, is proved to have various pharmacological activities with an undefined therapy mechanism. The objective of this research was to demonstrate the effect of punicalagin on anti-inflammatory and angiogenic activation in human umbilical vein en...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636678/ https://www.ncbi.nlm.nih.gov/pubmed/34867335 http://dx.doi.org/10.3389/fphar.2021.727920 |
_version_ | 1784608576822575104 |
---|---|
author | Liu, Wei Ou, Yanghui Yang, Yumeng Zhang, Xuemei Huang, Liqi Wang, Xiaohua Wu, Buling Huang, Mingcheng |
author_facet | Liu, Wei Ou, Yanghui Yang, Yumeng Zhang, Xuemei Huang, Liqi Wang, Xiaohua Wu, Buling Huang, Mingcheng |
author_sort | Liu, Wei |
collection | PubMed |
description | Punicalagin, a major ellagitannin isolated from pomegranate, is proved to have various pharmacological activities with an undefined therapy mechanism. The objective of this research was to demonstrate the effect of punicalagin on anti-inflammatory and angiogenic activation in human umbilical vein endothelial cells (HUVECs) and their potential mechanisms. Endothelial-leukocyte adhesion assay was applied to evaluate primary cultures of HUVECs activation following tumor necrosis factor alpha (TNF-α) treatment. The endothelial cell proliferation, migration, permeability and tube formation were assessed by EdU assay, wound migration assay, trans-endothelial electrical resistances (TEER) assay, and capillary-like tube formation assay, respectively. In addition, the expression of relevant proteins was assessed using Western blot analysis. We confirmed that punicalagin could reduce the adhesion of human monocyte cells to HUVECs in vitro and in vivo. Further, punicalagin decreased the expression of mRNA and proteins of ICAM-1 and VCAM-1 in HUVECs. Moreover, punicalagin inhibited permeability, proliferation, migration, and tube formation in VEGF-induced HUVECs, suppressed IKK-mediated activation of NF-κB signaling in TNF-α-induced endothelial cells, and inhibited vascular endothelial growth factor receptor 2 (VEGFR2) activation and downstream p-PAK1. Our findings indicated that punicalagin might have a protective effect on HUVECs activation, which suggested that punicalagin functions through an endothelial mediated mechanism for treating various disorders such as, cancer, rheumatoid arthritis, and cardiovascular disease. |
format | Online Article Text |
id | pubmed-8636678 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86366782021-12-03 Inhibitory Effect of Punicalagin on Inflammatory and Angiogenic Activation of Human Umbilical Vein Endothelial Cells Liu, Wei Ou, Yanghui Yang, Yumeng Zhang, Xuemei Huang, Liqi Wang, Xiaohua Wu, Buling Huang, Mingcheng Front Pharmacol Pharmacology Punicalagin, a major ellagitannin isolated from pomegranate, is proved to have various pharmacological activities with an undefined therapy mechanism. The objective of this research was to demonstrate the effect of punicalagin on anti-inflammatory and angiogenic activation in human umbilical vein endothelial cells (HUVECs) and their potential mechanisms. Endothelial-leukocyte adhesion assay was applied to evaluate primary cultures of HUVECs activation following tumor necrosis factor alpha (TNF-α) treatment. The endothelial cell proliferation, migration, permeability and tube formation were assessed by EdU assay, wound migration assay, trans-endothelial electrical resistances (TEER) assay, and capillary-like tube formation assay, respectively. In addition, the expression of relevant proteins was assessed using Western blot analysis. We confirmed that punicalagin could reduce the adhesion of human monocyte cells to HUVECs in vitro and in vivo. Further, punicalagin decreased the expression of mRNA and proteins of ICAM-1 and VCAM-1 in HUVECs. Moreover, punicalagin inhibited permeability, proliferation, migration, and tube formation in VEGF-induced HUVECs, suppressed IKK-mediated activation of NF-κB signaling in TNF-α-induced endothelial cells, and inhibited vascular endothelial growth factor receptor 2 (VEGFR2) activation and downstream p-PAK1. Our findings indicated that punicalagin might have a protective effect on HUVECs activation, which suggested that punicalagin functions through an endothelial mediated mechanism for treating various disorders such as, cancer, rheumatoid arthritis, and cardiovascular disease. Frontiers Media S.A. 2021-11-16 /pmc/articles/PMC8636678/ /pubmed/34867335 http://dx.doi.org/10.3389/fphar.2021.727920 Text en Copyright © 2021 Liu, Ou, Yang, Zhang, Huang, Wang, Wu and Huang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Liu, Wei Ou, Yanghui Yang, Yumeng Zhang, Xuemei Huang, Liqi Wang, Xiaohua Wu, Buling Huang, Mingcheng Inhibitory Effect of Punicalagin on Inflammatory and Angiogenic Activation of Human Umbilical Vein Endothelial Cells |
title | Inhibitory Effect of Punicalagin on Inflammatory and Angiogenic Activation of Human Umbilical Vein Endothelial Cells |
title_full | Inhibitory Effect of Punicalagin on Inflammatory and Angiogenic Activation of Human Umbilical Vein Endothelial Cells |
title_fullStr | Inhibitory Effect of Punicalagin on Inflammatory and Angiogenic Activation of Human Umbilical Vein Endothelial Cells |
title_full_unstemmed | Inhibitory Effect of Punicalagin on Inflammatory and Angiogenic Activation of Human Umbilical Vein Endothelial Cells |
title_short | Inhibitory Effect of Punicalagin on Inflammatory and Angiogenic Activation of Human Umbilical Vein Endothelial Cells |
title_sort | inhibitory effect of punicalagin on inflammatory and angiogenic activation of human umbilical vein endothelial cells |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636678/ https://www.ncbi.nlm.nih.gov/pubmed/34867335 http://dx.doi.org/10.3389/fphar.2021.727920 |
work_keys_str_mv | AT liuwei inhibitoryeffectofpunicalaginoninflammatoryandangiogenicactivationofhumanumbilicalveinendothelialcells AT ouyanghui inhibitoryeffectofpunicalaginoninflammatoryandangiogenicactivationofhumanumbilicalveinendothelialcells AT yangyumeng inhibitoryeffectofpunicalaginoninflammatoryandangiogenicactivationofhumanumbilicalveinendothelialcells AT zhangxuemei inhibitoryeffectofpunicalaginoninflammatoryandangiogenicactivationofhumanumbilicalveinendothelialcells AT huangliqi inhibitoryeffectofpunicalaginoninflammatoryandangiogenicactivationofhumanumbilicalveinendothelialcells AT wangxiaohua inhibitoryeffectofpunicalaginoninflammatoryandangiogenicactivationofhumanumbilicalveinendothelialcells AT wubuling inhibitoryeffectofpunicalaginoninflammatoryandangiogenicactivationofhumanumbilicalveinendothelialcells AT huangmingcheng inhibitoryeffectofpunicalaginoninflammatoryandangiogenicactivationofhumanumbilicalveinendothelialcells |